ACTR1A | ARP1 actin-related protein 1 homolog A, centractin alpha (yeast) | Cytoskeleton related proteins Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/37193/73551_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
ACTR2 | ARP2 actin-related protein 2 homolog (yeast) | Plasma proteins
| | ![](/images/15050/if_selected_60x60.jpg) | ![](/images/5083/ihc_cell_selected_60x60.jpg) | ![](/images/5083/13216_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
ACTR3 | ARP3 actin-related protein 3 homolog (yeast) | Plasma proteins
| ![](/images/51683/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | | ![](/images/51683/121263_A_8_6_rna_selected_60x60.jpg) | Expressed in all |
ACY1 | Aminoacylase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | ![](/images/36175/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/36174/98822_B_8_3_rna_selected_60x60.jpg) | Group enriched |
ACY3 | Aspartoacylase (aminocyclase) 3 | Enzymes
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/39219/83702_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
ADA | Adenosine deaminase | Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | ![](/images/4307/ihc_cell_selected_60x60.jpg) | ![](/images/23884/54930_B_9_3_rna_selected_60x60.jpg) | Tissue enriched |
ADAM10 | ADAM metallopeptidase domain 10 | Cancer-related genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| ![](/images/1709/ihc_selected_60x60.jpg) | | ![](/images/1709/ihc_cell_selected_60x60.jpg) | ![](/images/1709/4395_B_7_7_rna_selected_60x60.jpg) | Expressed in all |
ADAM12 | ADAM metallopeptidase domain 12 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/30866/72417_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
ADAM17 | ADAM metallopeptidase domain 17 | CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | ![](/images/10738/ihc_cell_selected_60x60.jpg) | ![](/images/10738/26586_B_7_1_rna_selected_60x60.jpg) | Expressed in all |
ADAM2 | ADAM metallopeptidase domain 2 | Enzymes Predicted membrane proteins
| | ![](/images/26581/if_selected_60x60.jpg) | ![](/images/24621/ihc_cell_selected_60x60.jpg) | ![](/images/26581/55144_B_9_5_rna_selected_60x60.jpg) | Tissue enriched |
ADAM8 | ADAM metallopeptidase domain 8 | CD markers Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/64637/143728_A_5_8_rna_selected_60x60.jpg) | Tissue enhanced |
ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| ![](/images/16394/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/16394/36382_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
ADAMTS13 | ADAM metallopeptidase with thrombospondin type 1 motif, 13 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | ![](/images/42014/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/42014/98164_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
ADAMTS9 | ADAM metallopeptidase with thrombospondin type 1 motif, 9 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/28567/62983_B_8_6_rna_selected_60x60.jpg) | Mixed |
ADAMTSL4 | ADAMTS-like 4 | Disease related genes Predicted secreted proteins
| | ![](/images/6279/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/6279/17967_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
ADAP1 | ArfGAP with dual PH domains 1 | | | | ![](/images_static/rna_center.gif) | ![](/images/12049/30046_B_8_6_rna_selected_60x60.jpg) | Mixed |
ADAR | Adenosine deaminase, RNA-specific | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | ![](/images/56157/121410_B_8_3_rna_selected_60x60.jpg) | Expressed in all |
ADARB1 | Adenosine deaminase, RNA-specific, B1 | Enzymes Plasma proteins
| ![](/images/18277/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/18277/42056_B_8_7_rna_selected_60x60.jpg) | Expressed in all |
ADAT1 | Adenosine deaminase, tRNA-specific 1 | Enzymes
| ![](/images/40713/ihc_selected_60x60.jpg) | | ![](/images/40713/ihc_cell_selected_60x60.jpg) | ![](/images/40713/89631_A_3_1_rna_selected_60x60.jpg) | Expressed in all |
ADCK3 | AarF domain containing kinase 3 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/18217/41186_B_9_7_rna_selected_60x60.jpg) | Tissue enriched |
ADCK4 | AarF domain containing kinase 4 | Disease related genes Enzymes Potential drug targets
| | ![](/images/27229/if_selected_60x60.jpg) | ![](/images/27229/ihc_cell_selected_60x60.jpg) | ![](/images/27277/61284_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
ADCY2 | Adenylate cyclase 2 (brain) | Enzymes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/38015/84094_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
ADCY3 | Adenylate cyclase 3 | Enzymes Plasma proteins Predicted membrane proteins
| ![](/images/10223/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/10223/25240_B_9_4_rna_selected_60x60.jpg) | Expressed in all |
ADCY8 | Adenylate cyclase 8 (brain) | Enzymes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/24291/53337_B_8_1_rna_selected_60x60.jpg) | Group enriched |
ADD1 | Adducin 1 (alpha) | Cytoskeleton related proteins Plasma proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/35873/114845_B_8_4_rna_selected_60x60.jpg) | Expressed in all |
ADD2 | Adducin 2 (beta) | Cytoskeleton related proteins
| | ![](/images_static/na_center.gif) | | ![](/images/9796/24747_B_1_7_rna_selected_60x60.jpg) | Group enriched |
ADD3 | Adducin 3 (gamma) | Cytoskeleton related proteins
| | | | ![](/images/35696/124479_B_9_8_rna_selected_60x60.jpg) | Expressed in all |
ADH1A | Alcohol dehydrogenase 1A (class I), alpha polypeptide | Enzymes FDA approved drug targets Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/60902/141575_B_8_3_rna_selected_60x60.jpg) | Tissue enriched |
ADH1B | Alcohol dehydrogenase 1B (class I), beta polypeptide | Enzymes FDA approved drug targets Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/60902/141575_B_8_3_rna_selected_60x60.jpg) | Group enriched |
ADH4 | Alcohol dehydrogenase 4 (class II), pi polypeptide | Enzymes Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/20525/47087_B_8_5_rna_selected_60x60.jpg) | Tissue enriched |
ADH5 | Alcohol dehydrogenase 5 (class III), chi polypeptide | Enzymes Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/44578/123080_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
ADH7 | Alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide | Enzymes
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/39695/89977_B_6_8_rna_selected_60x60.jpg) | Tissue enriched |
ADI1 | Acireductone dioxygenase 1 | Enzymes Predicted secreted proteins
| ![](/images/35403/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/35403/69882_B_9_3_rna_selected_60x60.jpg) | Expressed in all |
ADIPOQ | Adiponectin, C1Q and collagen domain containing | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/46467/ihc_cell_selected_60x60.jpg) | ![](/images/46467/104620_B_9_2_rna_selected_60x60.jpg) | Tissue enriched |
ADIRF | Adipogenesis regulatory factor | Plasma proteins
| ![](/images/26810/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/26810/57106_A_4_7_rna_selected_60x60.jpg) | Tissue enhanced |
ADK | Adenosine kinase | Disease related genes Enzymes FDA approved drug targets
| ![](/images/38409/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/38391/80914_A_3_7_rna_selected_60x60.jpg) | Expressed in all |
ADNP | Activity-dependent neuroprotector homeobox | Cancer-related genes Transcription factors
| | | ![](/images_static/rna_center.gif) | ![](/images/6371/17484_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
ADNP2 | ADNP homeobox 2 | Transcription factors
| ![](/images/7126/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/7126/18515_B_8_1_rna_selected_60x60.jpg) | Mixed |
ADO | 2-aminoethanethiol (cysteamine) dioxygenase | Enzymes
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/40437/93489_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
ADPRHL2 | ADP-ribosylhydrolase like 2 | Enzymes Predicted secreted proteins
| | | ![](/images/27104/ihc_cell_selected_60x60.jpg) | ![](/images/27141/58661_B_2_5_rna_selected_60x60.jpg) | Expressed in all |
ADPRM | ADP-ribose/CDP-alcohol diphosphatase, manganese-dependent | Enzymes Predicted membrane proteins
| ![](/images/23820/ihc_selected_60x60.jpg) | ![](/images/23820/if_selected_60x60.jpg) | | ![](/images/23820/52348_B_3_3_rna_selected_60x60.jpg) | Expressed in all |
ADRB1 | Adrenoceptor beta 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/67972/149849_A_9_5_rna_selected_60x60.jpg) | Tissue enhanced |
ADRBK1 | Adrenergic, beta, receptor kinase 1 | Enzymes Plasma proteins
| | ![](/images/48330/if_selected_60x60.jpg) | | ![](/images/37248/86035_A_9_6_rna_selected_60x60.jpg) | Expressed in all |
ADRM1 | Adhesion regulating molecule 1 | | | | ![](/images_static/rna_center.gif) | ![](/images/42266/93667_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
ADSL | Adenylosuccinate lyase | Disease related genes Enzymes Potential drug targets
| | | | ![](/images/19285/42511_B_2_5_rna_selected_60x60.jpg) | Expressed in all |
ADSS | Adenylosuccinate synthase | Enzymes Plasma proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/24400/52832_B_7_7_rna_selected_60x60.jpg) | Expressed in all |
AEN | Apoptosis enhancing nuclease | | ![](/images/48599/ihc_selected_60x60.jpg) | | ![](/images/48599/ihc_cell_selected_60x60.jpg) | ![](/images/48599/120138_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
AFAP1 | Actin filament associated protein 1 | | | | ![](/images_static/rna_center.gif) | ![](/images/15642/36001_A_3_8_rna_selected_60x60.jpg) | Mixed |
AFAP1L1 | Actin filament associated protein 1-like 1 | | | ![](/images/7329/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/7329/19606_B_9_2_rna_selected_60x60.jpg) | Mixed |
AFAP1L2 | Actin filament associated protein 1-like 2 | | ![](/images/37843/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/37843/76927_B_5_6_rna_selected_60x60.jpg) | Tissue enhanced |